13F

ANAB ANAPTYSBIO INC

2026Q1 · CUSIP 032724106 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
206
Δ holders QoQ
+27
Breadth percentile
Top 11%
Whale holders
108
Δ whales
+12
Inst. holding value
$1.6B
New positions
51
Closed positions
24
Price momentum (1Q)
+64.1%
Put / Call
1/3

Breadth history (34 quarters)

2018Q1: Δ+16 · h=132 2018Q2: Δ-7 · h=125 2018Q3: Δ+4 · h=129 2018Q4: Δ-8 · h=121 2019Q1: Δ+8 · h=129 2019Q2: Δ-2 · h=127 2019Q3: Δ-7 · h=120 2019Q4: Δ+4 · h=124 2020Q1: Δ-6 · h=118 2020Q2: Δ+5 · h=123 2020Q3: Δ+10 · h=133 2020Q4: Δ+5 · h=138 2021Q1: Δ-12 · h=126 2021Q2: Δ-2 · h=124 2021Q3: Δ+3 · h=127 2021Q4: Δ+11 · h=138 2022Q1: Δ-6 · h=132 2022Q2: Δ-7 · h=125 2022Q3: Δ-9 · h=116 2022Q4: Δ+4 · h=120 2023Q1: Δ-6 · h=114 2023Q2: Δ+3 · h=117 2023Q3: Δ+0 · h=117 2023Q4: Δ+3 · h=120 2024Q1: Δ+14 · h=134 2024Q2: Δ+2 · h=136 2024Q3: Δ+25 · h=161 2024Q4: Δ-24 · h=137 2025Q1: Δ+17 · h=154 2025Q2: Δ-4 · h=150 2025Q3: Δ+17 · h=167 2025Q4: Δ+12 · h=179 2026Q1: Δ+27 · h=206 2018Q1: holders=132 2018Q2: holders=125 2018Q3: holders=129 2018Q4: holders=121 2019Q1: holders=129 2019Q2: holders=127 2019Q3: holders=120 2019Q4: holders=124 2020Q1: holders=118 2020Q2: holders=123 2020Q3: holders=133 2020Q4: holders=138 2021Q1: holders=126 2021Q2: holders=124 2021Q3: holders=127 2021Q4: holders=138 2022Q1: holders=132 2022Q2: holders=125 2022Q3: holders=116 2022Q4: holders=120 2023Q1: holders=114 2023Q2: holders=117 2023Q3: holders=117 2023Q4: holders=120 2024Q1: holders=134 2024Q2: holders=136 2024Q3: holders=161 2024Q4: holders=137 2025Q1: holders=154 2025Q2: holders=150 2025Q3: holders=167 2025Q4: holders=179 2026Q1: holders=206 -27 -13.5 +0 +13.5 +27 102160217 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 11%
2025Q3 Top 20% +59.5% +159.2%
2025Q1 Top 14% -3.3% +69.9%
2024Q3 Top 13% -1.5% +9.9%
2018Q1 Top 13% -4.3% -27.4%

Options Sentiment

Put holders
1
QoQ: -2
Call holders
3
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.02
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+107.7%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1M 2022-09-30: $1M 2022-12-31: $7M 2023-03-31: $1M 2023-06-30: $3M 2023-09-30: $3M 2023-12-31: $9M 2024-03-31: $7M 2024-06-30: $11M 2024-09-30: $30M 2024-12-31: $43M 2025-03-31: $28M 2025-06-30: $22M 2025-09-30: $76M 2025-12-31: $108M 2026-03-31: $26M 2022-06-30: EPS -1.15 2022-09-30: EPS -1.18 2022-12-31: EPS -0.93 2023-03-31: EPS -1.58 2023-06-30: EPS -1.50 2023-09-30: EPS -1.41 2023-12-31: EPS -1.59 2024-03-31: EPS -1.64 2024-06-30: EPS -1.71 2024-09-30: EPS -1.14 2024-12-31: EPS -0.63 2025-03-31: EPS -1.28 2025-06-30: EPS -1.34 2025-09-30: EPS 0.52 2025-12-31: EPS 1.64 2026-03-31: EPS -1.84 0M 54M 108M $M -2.02 -0.11 1.80 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)